Literature DB >> 20919831

Role of cell cycle perturbations in the combination therapy of chemotherapeutic agents and radiation.

Bea Pauwels1, An Wouters, Marc Peeters, Jan B Vermorken, Filip Lardon.   

Abstract

The combination of radiotherapy with chemotherapeutic agents that sensitize tumor cells to ionizing radiation has long been regarded as a promising strategy to enhance cancer therapy. Many chemotherapeutic agents interact with radiation and enhance the cytotoxic or anti-tumor effect of radiation through a number of mechanisms. These include an increase in initial radiation damage, inhibition of cellular repair, cell cycle redistribution, enhancement of apoptosis, counteracting hypoxia and overcoming accelerated repopulation. This article focuses on the role of cell cycle perturbations in the radiosensitivity of cancer cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20919831     DOI: 10.2217/fon.10.104

Source DB:  PubMed          Journal:  Future Oncol        ISSN: 1479-6694            Impact factor:   3.404


  12 in total

1.  Strategies to optimize radiotherapy based on biological responses of tumor and normal tissue.

Authors:  Weidong Wang; Jinyi Lang
Journal:  Exp Ther Med       Date:  2012-05-30       Impact factor: 2.447

2.  Silencing PSME3 induces colorectal cancer radiosensitivity by downregulating the expression of cyclin B1 and CKD1.

Authors:  Wen Song; Cuiping Guo; Jianxiong Chen; Shiyu Duan; Yukun Hu; Ying Zou; Honggang Chi; Jian Geng; Jun Zhou
Journal:  Exp Biol Med (Maywood)       Date:  2019-10-20

3.  1-butyltryptophan inhibits cell proliferation, migration, and invasion through the Akt pathway in human gastric cancer cells.

Authors:  Ting Sun; Hua Tian; YangXun Xin
Journal:  Tumour Biol       Date:  2014-11-30

4.  αV integrin induces multicellular radioresistance in human nasopharyngeal carcinoma via activating SAPK/JNK pathway.

Authors:  Juanjuan Ou; Wei Luan; Jia Deng; Rina Sa; Houjie Liang
Journal:  PLoS One       Date:  2012-06-13       Impact factor: 3.240

5.  Mechanism-based screen establishes signalling framework for DNA damage-associated G1 checkpoint response.

Authors:  Elizabeth Richardson; Simon R Stockwell; He Li; Wynne Aherne; Maria Emanuela Cuomo; Sibylle Mittnacht
Journal:  PLoS One       Date:  2012-02-27       Impact factor: 3.240

Review 6.  Therapeutic Potential of Curcumin for the Treatment of Brain Tumors.

Authors:  Neil V Klinger; Sandeep Mittal
Journal:  Oxid Med Cell Longev       Date:  2016-10-11       Impact factor: 6.543

Review 7.  Alkaloids and Colon Cancer: Molecular Mechanisms and Therapeutic Implications for Cell Cycle Arrest.

Authors:  Haroon Khan; Waqas Alam; Khalaf F Alsharif; Michael Aschner; Samreen Pervez; Luciano Saso
Journal:  Molecules       Date:  2022-01-28       Impact factor: 4.411

8.  Targeted inhibition of mammalian target of rapamycin (mTOR) enhances radiosensitivity in pancreatic carcinoma cells.

Authors:  Zhi-Jun Dai; Jie Gao; Hua-Feng Kang; Yu-Guang Ma; Xiao-Bin Ma; Wang-Feng Lu; Shuai Lin; Hong-Bing Ma; Xi-Jing Wang; Wen-Ying Wu
Journal:  Drug Des Devel Ther       Date:  2013-03-19       Impact factor: 4.162

9.  Screening candidate microRNA-mRNA regulatory pairs for predicting the response to chemoradiotherapy in rectal cancer by a bioinformatics approach.

Authors:  Qiliang Peng; Junjia Zhu; Peipei Shen; Wenyan Yao; Yu Lei; Li Zou; Yingying Xu; Yuntian Shen; Yaqun Zhu
Journal:  Sci Rep       Date:  2017-09-12       Impact factor: 4.379

10.  Curcumin Loaded in Niosomal Nanoparticles Improved the Anti-tumor Effects of Free Curcumin on Glioblastoma Stem-like Cells: an In Vitro Study.

Authors:  Sajad Sahab-Negah; Fatemeh Ariakia; Mohammad Jalili-Nik; Amir R Afshari; Sahar Salehi; Fariborz Samini; Ghadir Rajabzadeh; Ali Gorji
Journal:  Mol Neurobiol       Date:  2020-05-19       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.